ClinicalTrials.Veeva

Menu

Gender-specific aEEGs and Outcome in Preterms

Medical University of Vienna logo

Medical University of Vienna

Status

Completed

Conditions

Gender Role Disorder, Male to Female Type

Study type

Observational

Funder types

Other

Identifiers

NCT01562236
gender148

Details and patient eligibility

About

Background and objectives: Male sex is a risk factor for poor neurodevelopmental outcome following preterm birth. The investigators aimed to investigate gender-related differences in amplitude-integrated electroencephalography (aEEG) and to correlate these findings with neurodevelopmental outcome.

Methods: Preterm infants born <30 weeks' gestational age between 2000 and 2002 were prospectively included. aEEGs obtained within the first two weeks of life were evaluated and classified according to background activity, sleep-wake cycling (SWC) and seizure activity. Outcome was assessed at three years.

Enrollment

148 patients

Sex

All

Ages

24 to 30 weeks old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • born<30 weeks gestational age
  • who had aEEGs in first 2 weeks of life
  • who were assessed for outcome at 3 years of age

Exclusion criteria

  • born>30 weeks gestational age
  • had no aEEGs in first 2 weeks of life
  • lost for follow-up at 3 years

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems